Leb Victoria, Stöcher Markus, Valentine-Thon Elizabeth, Hölzl Gabriele, Kessler Harald, Stekel Herbert, Berg Jörg
Institute of Laboratory Medicine, General Hospital Linz, A-4020 Linz, Graz, Austria.
J Clin Microbiol. 2004 Feb;42(2):585-90. doi: 10.1128/JCM.42.2.585-590.2004.
We report on the development of a fully automated real-time PCR assay for the quantitative detection of hepatitis B virus (HBV) DNA in plasma with EDTA (EDTA plasma). The MagNA Pure LC instrument was used for automated DNA purification and automated preparation of PCR mixtures. Real-time PCR was performed on the LightCycler instrument. An internal amplification control was devised as a PCR competitor and was introduced into the assay at the stage of DNA purification to permit monitoring for sample adequacy. The detection limit of the assay was found to be 200 HBV DNA copies/ml, with a linear dynamic range of 8 orders of magnitude. When samples from the European Union Quality Control Concerted Action HBV Proficiency Panel 1999 were examined, the results were found to be in acceptable agreement with the HBV DNA concentrations of the panel members. In a clinical laboratory evaluation of 123 EDTA plasma samples, a significant correlation was found with the results obtained by the Roche HBV Monitor test on the Cobas Amplicor analyzer within the dynamic range of that system. In conclusion, the newly developed assay has a markedly reduced hands-on time, permits monitoring for sample adequacy, and is suitable for the quantitative detection of HBV DNA in plasma in a routine clinical laboratory.
我们报告了一种用于定量检测乙二胺四乙酸(EDTA)血浆中乙型肝炎病毒(HBV)DNA的全自动实时聚合酶链反应(PCR)检测方法的开发情况。MagNA Pure LC仪器用于自动DNA纯化和PCR混合物的自动制备。实时PCR在LightCycler仪器上进行。设计了一种内部扩增对照作为PCR竞争物,并在DNA纯化阶段引入检测中,以监测样品是否合格。该检测方法的检测限为200拷贝/ml HBV DNA,线性动态范围为8个数量级。对来自1999年欧盟质量控制协作行动HBV能力验证小组的样本进行检测时,发现结果与该小组成员的HBV DNA浓度具有可接受的一致性。在对123份EDTA血浆样本进行的临床实验室评估中,发现在该系统的动态范围内,与通过罗氏HBV Monitor检测在Cobas Amplicor分析仪上获得的结果具有显著相关性。总之,新开发的检测方法显著减少了实际操作时间,允许监测样品是否合格,适用于常规临床实验室对血浆中HBV DNA的定量检测。